October
Medicinal Chemistry
Strategy Meeting Europe 2025
days
hours
minutes
seconds
What makes our strategy meetings unique?

Roundtable Discussions
Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking
With senior delegation from big pharma and innovative biotech from across Europe, you can network with peers from different locations, all in one place.

Personalised Agenda
Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems
We've partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics
We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers
The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.
Meet Our Facilitators
Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Medicinal Chemistry strategy meeting.

Alessandro Mazzacani
Director of Chemistry and IP Sitryx
Chandan Seth Nanda
Vice President of Target & Drug Discovery Pear Bio
Chris Tame
Founder and Chief Executive Officer Ternary Therapeutics
Chris Luckhurst
Head of Chemistry ThirtyFiveBio
Daniel Gironés
Managing Director Sapiens Natura Pharma
Elisabetta Chiarparin
Former SVP, Head of Discovery & Development Technologies Merck
Guido Koch
Chief Executive Officer Amphilix
Ismail Ijjaali, Ph.D
Director, EMEAI Field Application Scientist Team Revvity Signals
Markus Queisser
Scientific Director GSK
Matthew Fyfe
Chief Scientific Officer Outrun Tx
May Rezai
Chief Operations Officer MirZyme Therapeutics
Melina Hoffmann
Associate Syncona Investment Management Limited
Nicolas Triballeau, Ph.D
Director Revvity Signals
Stephen Harrison
Former CSO Nucleome Therapeutics
Steven Zimmer
CEO EPICOMBI THERAPEUTICS
Zayd Rasool
Board Member Kingston UniversityOur Agenda
See Which Topics Are Discussed at the Strategy Meeting
AI in drug discovery: An opportunity to pivot away from target-centric drug discovery?
Roundtable Tracks
1Strategies for Targeted Protein Degradation: A Dive into PROTACs, Molecular Glues, and the Undruggable Proteome
-Daniel Gironés
Managing Director
Sapiens Natura Pharma
Target Identification/Lead Optimization
Fragment Based Drug Discovery (Topic TBC)
-Stephen Harrison
Former CSO
Nucleome Therapeutics
Integrated Drug Discovery
From Hit to Lead: Accelerating Drug Discovery Through Cutting-Edge Chemistry and Innovative Screening Strategies (Topic TBC)
-May Rezai
Chief Operations Officer
MirZyme Therapeutics
Private Equity, Venture Capital & Strategic Partnerships
How does biotech and pharma react to the geopolitcal changes and how does this affect collaboration and partnering strategies
-Guido Koch
Chief Executive Officer
Amphilix
Roundtable Tracks
2Navigating Complexity in Emerging Modalities: Transforming PROTAC, Peptide, Oligonucleotide, and ADC Drug Discovery
-Nicolas Triballeau, Ph.D
Director
Revvity Signals
Revvity Signals
Target Identification/Lead OptimizationFragment Based Drug Discovery in the Spotlight: Emerging Trends in Hit Identification and Lead Optimization
Sponsor
Integrated Drug DiscoveryThe Data Integration Crisis in Drug Discovery
-Ismail Ijjaali, Ph.D
Director, EMEAI Field Application Scientist Team
Revvity Signals
Revvity Signals
Private Equity, Venture Capital & Strategic PartnershipsHow Strategic Partnerships Revolutionize Pharma R&D
Sponsor
Roundtable Tracks
3From Discovery to Application: Challenges in Using Chemical Probes for Degrader Development
-Markus Queisser
Scientific Director
GSK
Target Identification/Lead Optimization
Drugging Protein:Protein Interactions: Best practices in hit identification and lead optimization of undruggable complexes (Topic TBC)
-Chris Luckhurst
Head of Chemistry
ThirtyFiveBio
Integrated Drug Discovery
The Next Frontier in Therapeutic RNA: Exploring Computational and AI-Driven Approaches for Target Identification, mRNA Synthesis, and Small Molecule Integration (Topic TBC)
-Zayd Rasool
Board Member
Kingston University
Private Equity, Venture Capital & Strategic Partnerships
Redefining Drug Discovery Success Through Strategic and Venture Partnerships: Catalyzing Innovation Across Pharma R&D
-Matthew Fyfe
Chief Scientific Officer
Outrun Tx
Augmented Discovery: How Revvity Signals AI/ML Amplifies Scientific Discovery
Roundtable Tracks
4Emerging “Undruggable” Targets in Targeted Protein Degradation
-Markus Queisser
Scientific Director
GSK
Target Identification/Lead Optimization
AI-Driven Drug Discovery: Transforming Hit Identification and Lead Optimization (Topic TBC)
-Alessandro Mazzacani
Director of Chemistry and IP
Sitryx
Integrated Drug Discovery
Blood-Brain Barrier Penetration in Drug Discovery - Challenges, Innovations, and Future Directions (Topic TBC)
-Chandan Seth Nanda
Vice President of Target & Drug Discovery
Pear Bio
Private Equity, Venture Capital & Strategic Partnerships
The Role of Venture Partnerships in Drug Discovery
Fueling the Future: How Venture Capital is Reshaping Drug Discovery Innovation
See the full agenda and facilitator line-up
Reasons To Attend Our Strategy Meetings

Fully Interactive Format
There's only so much you can learn from presentations and lectures. Instead our interactive Roundtable Discussions let you debate the topics that really matter

Senior Decision Makers
All our Strategy Meetings are aimed at director level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard

Personalised Agendas
Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we'll create a personalised agenda just for you

Private and Intimate Networking
Small group discussions, private meetings, networking drinks - however you choose to make those important connections our Strategy Meetings have the solution
Become an official strategy meeting partner
Whatever your business needs, we can help. Get in touch for partnering opportunitiesExplore Highlight From The Past Events
Gain valuable insights, discover innovative solutions and connect with industry leaders through snapshots of our most successful gatherings.
Press play to hear what your colleagues had to say...





Hotel & Venue
Crowne Plaza London Docklands
Our hotel is a haven from the hustle & bustle of London life - you’ll find peace & tranquility in modern surroundings. We’re close to The O2 Arena, ExCeL Exhibition Centre & Canary Wharf.
Hotel Details Map & Directions Parking




Want to find out more?
Find out more details about our Strategy Meetings and other news and events.
Here To Help
Want to know more? Interested in sponsoring the event? Need help registering your team? Just get in touch and a member of the team will be happy to help.